Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 13/20 | 0.80 |
| ▸ | P2RY6 | Q15077 | 10/20 | 0.71 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystetine Triphosphate SCHEMBL15810768 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL315351 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL104629 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL18784962 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| SCHEMBL376516 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL4289439 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| SCHEMBL376515 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL104630 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL21311175 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 | |
| Cystetine Triphosphate SCHEMBL10044131 | 1.00 | P2RY2 (0.80) | P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 997 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686760-A1 | SIALYLTRANSFERASES FOR THE SYNTHESIS OF SIALYLATED GLYCANS, GLYCOCONJUGATES AND GLYCOPROTEINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-02-04 | — | — | EP | claimed |
| US-20250197905-A1 | LEGIONAMINIC ACID GLYCOSYLTRANSFERASES FOR CHEMOENZYMATIC SYNTHESIS OF GLYCANS AND GLYCOCONJUGATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-06-19 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| US-20240409571-A1 | CHEMOENZYMATIC SYNTHESIS OF N-ACETYLATED GANGLIOSIDES AND GLYCOSPHINGOSINES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-12 | — | — | US | claimed |
| WO-2024239431-A1 | METHOD FOR PHOSPHORYLATION OF NUCLEIC ACID AT 3' END AND LIBRARY CONSTRUCTION | 深圳华大智造科技股份有限公司 | 2024-11-28 | — | — | WO | claimed |
| US-20240076803-A1 | Method for Library Preparation in Next Generation Sequencing by Enzymatic DNA Fragmentation | Miltenyi Biotec B.V. & Co. KG (DE) | 2024-03-07 | — | — | US | claimed |
| CN-117399072-A | Ultra-small cerium-based metal organic framework nano enzyme and preparation method and application thereof | 华南理工大学 | 2024-01-16 | — | — | CN | claimed |
| WO-2023183781-A2 | LEGIONAMINIC ACID GLYCOSYLTRANSFERASES FOR CHEMOENZYMATIC SYNTHESIS OF GLYCANS AND GLYCOCONJUGATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-09-28 | — | — | WO | claimed |
| EP-4036248-A1 | METHOD FOR LIBRARY PREPARATION IN NEXT GENERATION SEQUENCING BY ENZYMATIC DNA FRAGMENTATION | Miltenyi Biotec B.V. & Co. KG (DE) | 2022-08-03 | — | — | EP | claimed |
| EP-2919795-B1 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | UNIV CALIFORNIA (US) | 2021-06-30 | — | — | EP | claimed |
| US-5958897-A | Method of treating sinusitis with uridine triphosphates and related compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 1999-09-28 | — | — | US | claimed |
| CN-1227491-A | Method for treating sinusitis with uridine triphosphates and related compounds | INSPIRE PHARMACEUTICALS INC (US) | 1999-09-01 | — | — | CN | claimed |
| CN-1226169-A | Use of uridine triphosphates and related compounds for prevention and treatment of pneumonia in immobilized patients | INSPIRE PHARMACEUTICALS INC (US) | 1999-08-18 | — | — | CN | claimed |
| EP-0897301-A1 | METHOD OF TREATING OTITIS MEDIA WITH URIDINE TRIPHOSPHATES AND RELATED COMPOUNDS | Inspire Pharmaceuticals, Inc. (US) | 1999-02-24 | — | — | EP | claimed |
| WO-1999001110-A1 | TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES | SDG, INC. (US) | 1999-01-14 | — | — | WO | claimed |
| WO-1998034593-A1 | METHOD OF TREATING DRY EYE DISEASE WITH PURINERGIC RECEPTOR AGONISTS | INSPIRE PHARMACEUTICALS, INC. (US) | 1998-08-13 | — | — | WO | claimed |
| US-5763447-A | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds | INSPIRE PHARMACEUTICALS (US) | 1998-06-09 | — | — | US | claimed |
| WO-1997029756-A1 | METHOD OF TREATING OTITIS MEDIA WITH URIDINE TRIPHOSPHATES AND RELATED COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. (US) | 1997-08-21 | — | — | WO | claimed |
| US-5334514-A | Reacting sialic acid with cytidine 5*-triphosphate in presence of cell extract of microorganism having cytidine 5*-monophospho-N-acetylneuraminic acid synthetase activity | CIBA VISION CORPORATION | 1994-08-02 | — | — | US | claimed |
| EP-0458070-A1 | Cytidine analogue resistance gene DNA and its use | Takeda Chemical Industries, Ltd. (JP) | 1991-11-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409571-A1 | CHEMOENZYMATIC SYNTHESIS OF N-ACETYLATED GANGLIOSIDES AND GLYCOSPHINGOSINES | B3GNT2, ST3GAL3, FUT6 | P2RY2 1590/4885P2RY6 1780/4885P2RY4 2294/4885 |
| US-20250197905-A1 | LEGIONAMINIC ACID GLYCOSYLTRANSFERASES FOR CHEMOENZYMATIC SYNTHESIS OF GLYCANS AND GLYCOCONJUGATES | FNTA, MAGT1, FNTB | P2RY2 4743/4885P2RY6 4061/4885P2RY4 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.